Equities research analysts expect AFLAC Incorporated (NYSE:AFL) to post $1.05 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for AFLAC’s earnings, with the lowest EPS estimate coming in at $1.03 and the highest estimate coming in at $1.07. AFLAC also reported earnings per share of $1.05 during the same quarter last year. The business is scheduled to announce its next earnings report on Wednesday, April 24th.
According to Zacks, analysts expect that AFLAC will report full year earnings of $4.22 per share for the current year, with EPS estimates ranging from $4.15 to $4.25. For the next year, analysts anticipate that the company will report earnings of $4.44 per share, with EPS estimates ranging from $4.40 to $4.50. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side analysts that follow AFLAC.
AFLAC (NYSE:AFL) last announced its quarterly earnings results on Thursday, January 31st. The financial services provider reported $1.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.08. The business had revenue of $5.48 billion for the quarter, compared to analyst estimates of $5.47 billion. AFLAC had a net margin of 13.42% and a return on equity of 13.62%.
Shares of AFLAC stock opened at $49.70 on Friday. The firm has a market capitalization of $37.06 billion, a price-to-earnings ratio of 11.95, a PEG ratio of 3.40 and a beta of 0.79. AFLAC has a 12-month low of $41.45 and a 12-month high of $49.71. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.06 and a current ratio of 0.06.
The business also recently announced a quarterly dividend, which was paid on Friday, March 1st. Stockholders of record on Wednesday, February 20th were paid a dividend of $0.27 per share. This is a positive change from AFLAC’s previous quarterly dividend of $0.26. The ex-dividend date was Tuesday, February 19th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 2.17%. AFLAC’s payout ratio is presently 25.96%.
In other AFLAC news, insider Audrey B. Tillman sold 2,100 shares of the company’s stock in a transaction that occurred on Friday, February 22nd. The shares were sold at an average price of $48.71, for a total transaction of $102,291.00. Following the completion of the sale, the insider now directly owns 105,017 shares of the company’s stock, valued at $5,115,378.07. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Richard Williams, Jr. sold 1,129 shares of the company’s stock in a transaction that occurred on Thursday, December 20th. The shares were sold at an average price of $43.97, for a total transaction of $49,642.13. Following the sale, the vice president now directly owns 14,577 shares of the company’s stock, valued at $640,950.69. The disclosure for this sale can be found here. Insiders have sold 64,765 shares of company stock valued at $3,120,127 over the last three months. 1.70% of the stock is owned by corporate insiders.
Institutional investors and hedge funds have recently bought and sold shares of the business. Financial Advantage Inc. bought a new position in shares of AFLAC during the fourth quarter worth $29,000. Nelson Roberts Investment Advisors LLC bought a new position in shares of AFLAC during the fourth quarter worth $33,000. IMS Capital Management bought a new position in shares of AFLAC during the third quarter worth $35,000. Vigilant Capital Management LLC bought a new position in shares of AFLAC during the fourth quarter worth $39,000. Finally, Transamerica Financial Advisors Inc. bought a new position in shares of AFLAC during the fourth quarter worth $41,000. Institutional investors and hedge funds own 66.64% of the company’s stock.
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.